These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5040598)

  • 1. Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis.
    Isacson S; Nilsson IM
    Acta Chir Scand; 1972; 138(4):313-9. PubMed ID: 5040598
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of coagulation and fibrinolysis in 131 cases of recurrent deep vein thrombosis].
    Conard J; Veuillet-Duval A; Horellou MH; Samama M
    Nouv Rev Fr Hematol (1978); 1982; 24(3):205-9. PubMed ID: 7133990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thrombolytic therapy].
    Schmutzler R; Koller F
    Ergeb Inn Med Kinderheilkd; 1965; 22():157-210. PubMed ID: 5889464
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial: Venous thrombosis and venous thrombolysis.
    Med J Aust; 1973 Dec; 2(24):1078-9. PubMed ID: 4775820
    [No Abstract]   [Full Text] [Related]  

  • 5. The muscle as a possible source of plasminogen activator to the blood and their therapeutic implication in the prevention of deep vein thrombosis.
    Menon IS
    Acta Univ Carol Med Monogr; 1972; 52():181-4. PubMed ID: 4669820
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of plasminogen activator present in the endothelium of venous vessels on the development of thrombotic diseases].
    Czestochowska E
    Pol Tyg Lek; 1974 Apr; 29(14):587-9. PubMed ID: 4828036
    [No Abstract]   [Full Text] [Related]  

  • 7. [Quantitative and qualitative hemostatic changes in 373 patients with recurring venous thromboses].
    Marbet GA; Duckert F; Biland L; Widmer LK
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1505-6. PubMed ID: 4081679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired fibrinolytic capacity predisposes for recurrence of venous thrombosis.
    Korninger C; Lechner K; Niessner H; Gössinger H; Kundi M
    Thromb Haemost; 1984 Oct; 52(2):127-30. PubMed ID: 6523430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinolytic response in retinal venous occlusions and in diabetic retinopathy].
    Peduzzi M; De Rosa L; Montanari F; Coccheri S
    Bull Mem Soc Fr Ophtalmol; 1978; 90():79-82. PubMed ID: 750023
    [No Abstract]   [Full Text] [Related]  

  • 10. Relation of blood coagulation, fibrinolysis and platelet aggregation tests to development of deep vein thrombosis in high risk medical patients.
    Stegnar M; Accetto B; Budihna N; Miklavcic L
    Acta Med Iugosl; 1981; 35(4):259-67. PubMed ID: 7325003
    [No Abstract]   [Full Text] [Related]  

  • 11. [Indicators of hemostasis in acute venous thrombosis].
    Savel'ev VS; Dumpe EP; Shestakov VA; Iablokov EG; Il'in VN
    Khirurgiia (Mosk); 1976 May; (5):18-22. PubMed ID: 966518
    [No Abstract]   [Full Text] [Related]  

  • 12. [Decreased fibrinolytic activity in venous walls of patients with venous thromboses].
    Hach V; Heyland H; Walter-Fincke R; Scharrer I
    Vasa; 1985; 14(4):336-9. PubMed ID: 4072368
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of desmopressin (DDAVP) in the detection of decreased fibrinolytic capacity in persons with idiopathic venous thrombosis and myocardial infarct at a young age].
    Cepelák V; Dvorák J
    Vnitr Lek; 1985 Mar; 31(3):232-9. PubMed ID: 4036009
    [No Abstract]   [Full Text] [Related]  

  • 14. "Fibrinolytic capacity" in healthy volunteers as estimated from effect of venous occlusion of arms.
    Robertson BR; Pandolfi M; Nilsson IM
    Acta Chir Scand; 1972; 138(5):429-36. PubMed ID: 5055974
    [No Abstract]   [Full Text] [Related]  

  • 15. [Arterial and venous thrombosis of the extremities].
    Urano T; Sakaguchi S; Kamiya T; Ishii K; Takada Y; Takada A
    Rinsho Ketsueki; 1984 Jul; 25(7):1036-42. PubMed ID: 6502955
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study.
    Crowther MA; Roberts J; Roberts R; Johnston M; Stevens P; Skingley P; Patrassi GM; Sartori MT; Hirsh J; Prandoni P; Weitz JI; Gent M; Ginsberg JS
    Thromb Haemost; 2001 Mar; 85(3):390-4. PubMed ID: 11307802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A family with reduced plasminogen activator activity in the blood associated with recurrent thrombosis].
    Jørgensen M; Mortensen JZ; Madsen AG; Thorsen S; Jacobsen B
    Ugeskr Laeger; 1983 Jul; 145(30):2302-3. PubMed ID: 6685363
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical surgery and fibrinolysis].
    Murakami F; Kadota H
    Saishin Igaku; 1966 Feb; 21(2):284-91. PubMed ID: 5966315
    [No Abstract]   [Full Text] [Related]  

  • 19. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fibrinolytic system and postoperative thrombosis following operation of rectal carcinoma. A preliminary report.
    Aberg M; Isacson S; Nilsson IM
    Acta Chir Scand; 1974; 140(5):352-4. PubMed ID: 4854836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.